Skip to main content
Cometriq-H-C-PSUSA-00010180-201603: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Cometriq-H-C-PSUSA-00010180-201603: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

153 wyświetleń
Pobierz
Farmaceutyczny

Cometriq-H-C-PSUSA-00010180-201603: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Zaawansowana formuła farmaceutyczna do celowanego działania terapeutycznego.

Dawkowanie

Cometriq-H-C-PSUSA-00010180-201603: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Moc

Cometriq-H-C-PSUSA-00010180-201603: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Wielkość opakowania

Cometriq-H-C-PSUSA-00010180-201603: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Postać

Cometriq-H-C-PSUSA-00010180-201603: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Źródło

European Medicines Agency

Zobacz źródło

Profil bezpieczeństwa

Przeciwwskazania

Cometriq-H-C-PSUSA-00010180-201603: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Skutki uboczne

Cometriq-H-C-PSUSA-00010180-201603: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Powiązane artykuły kliniczne